The Exonerator
By Jennifer S. Forsyth and Leslie Eaton,
Wall Street Journal
| 11. 15. 2008
Craig Watkins may be the only prosecutor in America who is making his name getting people out of prison.
As district attorney of Dallas County, Mr. Watkins is using DNA evidence to investigate more than 400 guilty verdicts notched up by his predecessors. His office's Conviction Integrity Unit, launched last year for this purpose, has so far cleared six men wrongly convicted of rape, murder or robbery.
In the past two decades, more than 200 convicts nationwide have been freed thanks in part to DNA testing. The tests involve taking biological material such as blood from the person convicted and comparing it to a sample left at the crime scene. These efforts are usually spearheaded by defense lawyers, not prosecutors.
Mr. Watkins, who became the first African American district attorney in Texas when he was elected in 2006, said in a recent interview that he has been accused of being "a criminal-loving DA, a hug-a-thug DA." But he says such criticism of him and his office misses the point: "We have the constitutional obligation to seek justice."
Each exoneration has...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...